Towards personalized medicine: a scoping review of immunotherapy in sepsis

Keyphrases

• Sepsis 100%
• Personalized Medicine 100%
• Scoping Review 100%
• Personalized Approach 66%
• Immunomodulatory Therapy 66%
• Personalized Cancer Therapy 66%
• Clinical Trials 33%
• Clinical Research 33%
• Growth Factors 33%
• Conflicting Results 33%
• Randomized Controlled Trial 33%
• Treatment Group 33%
• Laboratory Parameters 33%
• Innate Immune Response 33%
• Patient-centered 33%
• Embase 33%
• PubMed 33%
• Intravenous Immunoglobulin (IVIg) 33%
• Clinical Benefit 33%
• Mesenchymal Stem Cells 33%
• Complement System 33%
• Data-driven Assessment 33%
• Adult Patients 33%
• Life-limiting Conditions 33%
• Targeted Treatment 33%
• Cochrane 33%
• Endothelial Dysfunction 33%
• Variable Temperature 33%
• Immunosuppressive Cytokines 33%
• Cytokine Factors 33%
• Immune Profile 33%
• Abstract Screening 33%
• Sepsis Patients 33%
• Patient Stratification 33%
• Concomitant Treatment 33%
• Pleiotropic Drugs 33%
• Traditional Chinese Medicine 33%
• Laboratory Genetics 33%
• Immunonutrition 33%
• Coagulation Dysfunction 33%
• Immune Checkpoint Inhibitors 33%
• Potential Influencing Factors 33%
• Immune Dysregulation 33%
• Laboratory Biomarkers 33%
• Immunotherapy Approaches 33%
• Genetic Variables 33%
• Sepsis Pathophysiology 33%

Immunology and Microbiology

• Immunotherapy 100%
• Intravenous Immunoglobulin 25%
• Innate Immune System 25%
• Cytokine 25%
• Mesenchymal Stem Cell 25%
• Growth Factor 25%
• Complement System 25%
• Medline 25%
• Cochrane Library 25%
• Immune Dysregulation 25%
• Embase 25%
• Immune Checkpoint Inhibitor 25%